Cargando…
Integrated Bioinformatics Investigation of Novel Biomarkers of Uterine Leiomyosarcoma Diagnosis and Outcome
Uterine leiomyosarcomas (uLMS) have a poor prognosis and a high percentage of recurrent disease. Bioinformatics has become an integral element in rare cancer studies by overcoming the inability to collect a large enough study population. This study aimed to investigate and highlight crucial genes, p...
Autores principales: | Rakic, Aleksandar, Anicic, Radomir, Rakic, Marija, Nejkovic, Lazar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10302315/ https://www.ncbi.nlm.nih.gov/pubmed/37373974 http://dx.doi.org/10.3390/jpm13060985 |
Ejemplares similares
-
A Rare Case of Epithelioid Trophoblastic Tumor Presenting as Hematoma of a Caesarean Scar in the Lower Uterine Segment
por: Aničić, Radomir, et al.
Publicado: (2021) -
Molecular Insights in Uterine Leiomyosarcoma: A Systematic Review
por: Sparić, Radmila, et al.
Publicado: (2022) -
Gamma-glutamyltransferase as novel biomarker in patients with uterine leiomyosarcoma
por: Schwameis, Richard, et al.
Publicado: (2016) -
Potential Biomarker for Human Uterine Leiomyosarcoma
por: Hayashi, Takuma, et al.
Publicado: (2014) -
Uterine Leiomyosarcoma
por: Byar, Katherine L., et al.
Publicado: (2022)